Stock Events

Stock Events

Glaukos 

€149.00
39
-€2.00-1.32% Tuesday 13:32

Statistics

Day High
150
Day Low
147
52W High
164
52W Low
63
Volume
-
Avg. Volume
-
Mkt Cap
8.79B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2026
Q2 2026
Next
-0.24
-0.19
-0.13
-0.08
Expected EPS
-0.08151330957
Actual EPS
N/A

Financials

-36.66%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
439.64MRevenue
-161.19MNet Income

Analyst Ratings

139.70Average Price Target
The highest estimate is 153.28.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
90%
Hold
10%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6GJ.STU. It's not an investment recommendation.
Amazon
12
AMZN
AMD
12
AMD
Apple
11
AAPL
Verizon Communications
11
VZ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap11.27B
Align Technology competes in the broader medical devices sector, focusing on dental products but shares market space in medical technology advancements.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical technologies which can overlap with Glaukos' market.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie, while primarily known for pharmaceuticals, has interests in eye care through its acquisition of Allergan, making it a competitor in the ophthalmology space.
Novartis
NVS
Mkt Cap304.1B
Novartis competes directly in the eye care market through its Alcon division, offering products and solutions in eye health that rival Glaukos' offerings.
Staar Surgical
STAA
Mkt Cap1.18B
STAAR Surgical specializes in ophthalmic products, directly competing with Glaukos in the market for surgical eye care solutions.
Bausch Health Companies
BHC
Mkt Cap2.45B
Bausch Health Companies, through its eye health division, competes in the same ophthalmology and eye care markets as Glaukos.
Cooper Companies
COO
Mkt Cap13.57B
The Cooper Companies operate in the medical device sector focusing on contact lens and women's health, but its eye care division competes with Glaukos in providing medical devices for eye conditions.
Integra Lifesciences
IART
Mkt Cap1.3B
Integra LifeSciences, a provider of medical devices for surgery, competes indirectly with Glaukos through its offerings in surgical instruments and regenerative technologies.

About

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Show more...
CEO
Thomas William Burns
Employees
1094
Country
United States
ISIN
US3773221029
WKN
000A14VCK

Listings

XETRA
DE
6GJ.XETRA
STU
DE
6GJ.STU
MU
DE
6GJ.MU
BOATS
BOATS
GKOS.BOATS

0 Comments

Share your thoughts

FAQ

What is Glaukos stock price today?▼
The current price of 6GJ.STU is €149.00 EUR — it has decreased by -1.32% in the past 24 hours. Watch Glaukos stock price performance more closely on the chart.
What is Glaukos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Glaukos stocks are traded under the ticker 6GJ.STU.
Is Glaukos stock price growing?▼
6GJ.STU stock has fallen by -3.25% compared to the previous week, the month change is a +0.68% rise, over the last year Glaukos has showed a +94.77% increase.
What is Glaukos market cap?▼
Today Glaukos has the market capitalization of 8.79B
When is the next Glaukos earnings date?▼
Glaukos is going to release the next earnings report on November 04, 2026.
What were Glaukos earnings last quarter?▼
6GJ.STU earnings for the last quarter are -0.12 EUR per share, whereas the estimation was -0.18 EUR resulting in a +33.5% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Glaukos revenue for the last year?▼
Glaukos revenue for the last year amounts to 439.64M EUR.
What is Glaukos net income for the last year?▼
6GJ.STU net income for the last year is -161.19M EUR.
How many employees does Glaukos have?▼
As of September 09, 2026, the company has 1,094 employees.
In which sector is Glaukos located?▼
Glaukos operates in the Health & Wellness sector.
When did Glaukos complete a stock split?▼
Glaukos has not had any recent stock splits.
Where is Glaukos headquartered?▼
Glaukos is headquartered in ALISO VIEJO, United States.